Australia’s medical regulator has recommended no changes to the vaccine rollout despite blood clotting in a recipient of the AstraZeneca jab.
Several urgent meetings have been held today after the 44-year-old was admitted to Melbourne’s Box Hill Hospital with abdominal pain.
Acting Chief Medical Officer Professor Michael Kidd said, “at this time the risk of serious disease and death from COVID-19 if we experience a severe outbreak especially among older Australians is far greater than the very small potential risk of a very rare clotting disorder”.
People who experience unusual headaches 4-20 days after vaccination are being told to seek medical advice as soon as possible.
The TGA is working with European regulators as investigations continue and further advice is expected in the coming days.
By Joe Cusmano
Virgin Australia Holidays Relaunches with Bundled Getaways 
Swan Hellenic Brings True Expedition Cruising Closer to Home 
Ponant Unveils 2026 Close to Home Voyages for ANZ Travellers 
Why Aussies Are Rethinking Travel Plans in 2026 
Qantas Levels Up Its Ultra-Long-Haul Game 
Australia to Europe: The Most Notable Airline Routes (And How To Book Around the Chaos) 
Riyadh Air Commences Daily Dubai-Riyadh Flights as Inaugural Flight Takes Flight 
HANSEATIC Spirit Completes First Major Docking with Fresh Nature-Inspired Look 
Coral Expeditions and Australian Geographic Launch New Kimberley Photography Voyages 
Waldorf Astoria London – Admiralty Arch Opens for Reservations Ahead of Autumn Debut 